1Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol 8: 729–740.
2Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during aging of human fibroblasts 345: 458 – 460.
3Ben-Porath I, Weinberg R (2005) The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37: 961–976.
4Blackburn EH (2000) Telomere states and cell fates. Nature 408: 53–56.
5Blackburn EH (2001) Switching and signaling at the telomere. Cell 106: 661–673.
6Morgan RG, Ives SJ, Lesniewski L, Cawthon RM, Andtbacka RHI, et al. (2013) Age-related telomere uncapping is associated with cellular senescence and inflammation independent of telomere shortening in human arteries. Am. J. Physiol, Heart Circ Physioln 251–258.
7Blackburn EH (2005) Telomerase and Cancer: Kirk A. Landon--AACR prize for basic cancer research lecture. Mol Cancer Res 3: 477–482.
8Proctor CJ, Kirkwood TBL (2003) Modelling cellular senescence as a result of telomere state. Aging Cell 2: 151–157.
9Bakkenist CJ, Drissi R, Wu J, Kastan MB, Dome JS (2004) Disappearance of the Telomere Dysfunction-Induced Stress Response in Fully Senescent Cells Advances in Brief Disappearance of the Telomere Dysfunction-Induced Stress Response in Fully Senescent Cells. Cancer Res 64: 3748–3752.
10Kulju KS, Lehman JM (1995) Increased p53 protein associated with aging in human diploid fibroblasts. Exp Cell Res 217: 336–45.
11Shieh SY, Ikeda M, Taya Y, Prives C (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325–34.
12Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al. (1998) Extension of Life-Span by Introduction of Telomerase into Normal Human Cells. Science 279: 349–352.
13Minamino T, Mitsialis SA, Kourembanas S (2001) Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol 21: 3336–3342.
14Chitalia VC, Shivanna S, Martorell J, Balcells M, Bosch I, et al. (2013) Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation 127: 365–76.
15Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko, et al. (2008) Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat. Cell Biol 10: 1208–1216.
16Xue W, Zender L, Miething C, Dickins R, Hernando E, et al. (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656–660.
17Vogelstein B, Kinzler KW (1992) p 53 Function and Dysfunction Minireview. Cell 70: 523–526.
18Waldman T, Kinzler KW, Vogelstein B (1995) p21 Is Necessary for the p53-mediated G 1 Arrest in Human Cancer Cells Advances in Brief p2 ! Is Necessary for the p53-mediated G, Arrest in Human Cancer Cells. Cancer Res 55: 5187–5190.
19Rufini, Tucci P, Celardo I, Melino G (2013) Senescence and aging: the critical roles of p53. Oncogene 32: 5129–43.
20Ryan KM, Ernst MK, Rice NR, Vousden KH (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature 404: 892–897.
21Perez-Reyes N, Halbert CL, Smith PP, Benditt EP, McDougall JK (1992) Immortalization of primary human smooth muscle cells. Proc Natl Acad Sci USA 89: 1224–1228.
22 Sebastian T, Johnson PF (2009) RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence. Cancer Res 69: 2588–2598.
23Lee KM, Choi KH, Ouellette MM (2004) Use of exogenous hTERT to immortalize primary human cells. Cytotechnology 45: 33–38.
24Wazer DE, Liu XL, Chu Q, Gao Q, Band V (1995) Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci USA 92: 3687–3691.
25De Filippis L, Ferrari D, Rota Nodari L, Amati B, Snyder E, et al. (2008) Immortalization of human neural stem cells with the c-myc mutant T58A. PLoS One 3: e3310.
26Liu JP, Cassar L, Pinto A, Li H (2006) Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma. Cell Res. 16: 809–817.
27Lehman T, Modali R, Boukamp P, Stanek J, Bennett WP, et al. (1993) P53 Mutations in Human Immortalized Epithelial Cell Lines. Carcinogenesis 14: 833–839.
28Neufeld DS, Ripley S, Henderson ANN, Ozer HL (1987) Immortalization of Human Fibroblasts Transformed by Origin-Defective Simian Virus 40. Mol Cell Biol 7.
29Legrand, Greenspan P, Nagpal ML, Nachtigal S, Nachtigal M (1991) Characterization of human vascular smooth muscle cells transformed by the early genetic region of SV40 virus. Am J Pathol 139: 629–40.
30Carmean N, Kosman JW, Leaf EM, Hudson E, Opheim KE., et al. (2007) Immortalization of human urothelial cells by human papillomavirus type 16 E6 and E7 genes in a defined serum-free system. Cell Prolif 40: 166–184.
31Ouellette MM, McDaniel LD, Wright WE, Shay JW, Schultz R (2000) The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum Mol Genet 9: 403–411.
32Hu JIZ, Ang HEW, Ishop JMIB, Lackburn ELHB (1999) Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci 96: 3723–3728.
33Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96: 701–712.
34Harrington L, Zhou W, McPhail T, Oulton R, Yeung DSK, et al. (19997) Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 11: 3109–3115.
35Mitterberger MC, Lechner S, Mattesich M, Zwerschke W (2014) Adipogenic differentiation is impaired in replicative senescent human subcutaneous adipose-derived stromal/progenitor cells. J Gerontol A Biol Sci Med Sci 69: 13–24.
36Rambhatla L, Chiu CP, Glickman RD, Rowe-Rendleman C (2002) In vitro differentiation capacity of telomerase immortalized human RPE cells. Invest Ophthalmol Vis Sci 43: 1622–1630.
37Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa, et al. (2000) Adenoviral Expression of p53 Represses Telomerase Activity through Down-Regulation of Human Telomerase Reverse Transcriptase Transcription. Clin Cancer Res 6: 1239–1247.
38Karlseder J (1999) p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2. Science 283: 1321–1325.
39Appella E, Anderson CW (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268: 2764–2772.
40Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, et al. (2004) Regulation of p53 activity through lysine methylation. Nature 432: 353–360.
41Vogelstein B, Lane D, Levine J (2000) Surfing the p53 network. Nature 408: 307–310.
42Kuilman T, Michaloglou C, Mooi WJ, Peeper DS (2010) The essence of senescence. Genes Dev 24: 2463–2479.
43Kondoh M, Ohga N, Akiyama K, Hida Y, Maishi N, et al. (2013) Hypoxia-Induced Reactive Oxygen Species Cause Chromosomal Abnormalities in Endothelial Cells in the Tumor Microenvironment. PLoS One 8: e80349.
44Giaccia J, Kastan MB (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12: 2973–2983.
45Bai L, Zhu W (2006) p53 : Structure , Function and Therapeutic Applications. J Cancer Mol 2: 141–153.
46Vousden KH, Lu X (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594–604.